Palisade Bio Inc (PALI)
6.71
-0.23
(-3.31%)
USD |
NASDAQ |
May 10, 16:00
6.76
+0.05
(+0.75%)
After-Hours: 20:00
Palisade Bio Enterprise Value: -6.559M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | -6.559M |
| May 09, 2024 | -6.363M |
| May 08, 2024 | -6.261M |
| May 07, 2024 | -5.546M |
| May 06, 2024 | -5.069M |
| May 03, 2024 | -5.682M |
| May 02, 2024 | -6.065M |
| May 01, 2024 | -6.244M |
| April 30, 2024 | -7.138M |
| April 29, 2024 | -7.010M |
| April 26, 2024 | -7.121M |
| April 25, 2024 | -6.968M |
| April 24, 2024 | -6.866M |
| April 23, 2024 | -7.232M |
| April 22, 2024 | -8.075M |
| April 19, 2024 | -8.262M |
| April 18, 2024 | -7.955M |
| April 17, 2024 | -6.653M |
| April 16, 2024 | -7.223M |
| April 15, 2024 | -8.730M |
| April 12, 2024 | -8.764M |
| April 11, 2024 | -8.543M |
| April 10, 2024 | -8.807M |
| April 09, 2024 | -7.657M |
| April 08, 2024 | -7.138M |
| Date | Value |
|---|---|
| April 05, 2024 | -7.553M |
| April 04, 2024 | -7.374M |
| April 03, 2024 | -7.304M |
| April 02, 2024 | -7.388M |
| April 01, 2024 | -7.289M |
| March 28, 2024 | -7.175M |
| March 27, 2024 | -7.224M |
| March 26, 2024 | -7.511M |
| March 25, 2024 | -7.639M |
| March 22, 2024 | -7.494M |
| March 21, 2024 | -7.294M |
| March 20, 2024 | -7.683M |
| March 19, 2024 | -7.784M |
| March 18, 2024 | -7.872M |
| March 15, 2024 | -7.899M |
| March 14, 2024 | -7.814M |
| March 13, 2024 | -7.686M |
| March 12, 2024 | -7.735M |
| March 11, 2024 | -7.507M |
| March 08, 2024 | -7.590M |
| March 07, 2024 | -7.524M |
| March 06, 2024 | -7.221M |
| March 05, 2024 | -7.352M |
| March 04, 2024 | -7.444M |
| March 01, 2024 | -7.323M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.03M
Minimum
Aug 16 2023
75.00M
Maximum
Apr 28 2021
4.099M
Average
-1.441M
Median
Apr 11 2023
Enterprise Value Benchmarks
| TG Therapeutics Inc | 2.460B |
| Protagenic Therapeutics Inc | 1.910M |
| Bio-Path Holdings Inc | 0.7943M |
| Jaguar Health Inc | 113.23M |
| Finch Therapeutics Group Inc | -21.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.971M |
| Total Expenses (Quarterly) | 3.291M |
| EPS Diluted (Quarterly) | -3.75 |
| Earnings Yield | -404.6% |